Related Experiment Video
Updated: May 19, 2026

Measuring Trans-Plasma Membrane Electron Transport by C2C12 Myotubes
Published on: May 4, 2018
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt1, Dan Gibson
1The Institute for Drug Research, Hebrew University of Jerusalem, Jerusalem, Israel.
Abstract:
Platinum(IV) pro-drugs are an important class of molecules that might improve the pharmacological properties of the platinum(II) anticancer agents that are currently used in the clinic. Their axial ligands that are detached during cellular activation by reductive elimination can be used to confer favorable pharmacological properties to the complexes allowing for potentially lower toxicity and improved efficacy. This manuscript describes the various approaches taken to design and prepare Pt(IV) complexes that will be effective anticancer agents. We review the working hypotheses guiding the researchers in the field while pointing out some more recent results that contradict some of the accepted paradigms in the hope of triggering some rethinking of the existing working hypotheses.
Related Concept Videos
Prodrugs
Prodrugs help overcome...
Phase I Reactions: Reductive Reactions
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Drug Metabolism: Phase II Reactions
Drug Biotransformation: Overview
Drug Biotransformation: Overview

